Font: Financial Modeling Prep • Apr 02, 2026
Craig-Hallum lowered its price target on Vital Farms (NASDAQ: VITL) to $20 from $55 while maintaining a Buy rating, with shares declining more than 2% intraday Thursday.
The firm noted that Vital Farms remains the leading brand in the rapidly growing pasture-raised egg category and continues to aim to position itself as a trusted food company. However, the stock has faced significant pressure since management reduced its fiscal 2026 guidance in February, with subsequent scanner data indicating inconsistent and at times weak volume trends.
According to the analyst, these trends reflect intensifying competition across the broader egg market and within the pasture-raised segment. Competing brands have introduced aggressive promotional strategies, including discounts of up to 50% and buy-one-get-one offers, leading to volatility in retailer orders, inventory levels, and warehouse allocation, as well as reduced shelf space for Vital Farms products.
Despite these near-term challenges, the firm noted that underlying consumer demand indicators remain healthy, and discussions with retailers regarding spring shelf resets have been progressing positively.
Craig-Hallum maintained a constructive long-term outlook, citing the company’s brand strength and growth potential, particularly at current valuation levels. However, the firm adjusted its estimates to reflect near-term headwinds related to pricing pressure and shelf space constraints.
The new $20 price target is based on an 8.9x EV/EBITDA multiple applied to the firm’s reduced fiscal 2027 estimates.
|
GV§>
Visionary Holdings Inc.
|
$0.44
116.78%
|
|
LNKS§>
Linkers Industries Limited
|
$0.01
-35.16%
|
|
AIXI§>
Xiao-I Corporation
|
$0.13
33.10%
|
|
SKYQ§>
Sky Quarry Inc.
|
$5.10
101.58%
|
|
NVDA§>
NVIDIA Corporation
|
$177.39
0.93%
|
|
BITO§>
ProShares - Bitcoin ETF
|
$9.21
-1.60%
|
|
COCP§>
Cocrystal Pharma, Inc.
|
$1.51
48.04%
|
|
TSLL§>
Direxion Daily TSLA Bull 2X ETF
|
$11.37
-10.96%
|
|
SPDN§>
Direxion Daily S&P 500 Bear 1X ETF
|
$9.87
0.10%
|
|
BDRX§>
Biodexa Pharmaceuticals Plc
|
$0.87
42.23%
|